Publications by authors named "Xiubi Chen"

Claim this Profile
S
Safety evaluation of deucravacitinib: a real-world analysis based on the FDA adverse event reporting system database.
Haowen Tan, Xiubi Chen, Xuan Ou, Ying Chen

Int J Clin Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system.
Bowen Wang, Zheyun Song, Shan Lan, Xiubi Chen, Xida Yan

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system.
Haowen Tan, Xiubi Chen, Ying Chen, Xuan Ou, Tao Yang

J Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quantity, reliability, transparency, reporting, and interpretation of pharmacovigilance signal detection studies in pregnancy: a meta-epidemiological study.
Xue-Feng Jiao, Zhengyang Zhang, Lixiong Gong, Shan Lan, Songzhen Zhang, Xiubi Chen

Eur J Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of the safety profiles between inclisiran and other PCSK9 inhibitors from real-world evidence - what have we learned recently?
Su Zhou, Zuyue Liao, Xiubi Chen, Jiong Tang, Yu Wang

Expert Opin Drug Saf· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis